Lan Bo Chen
Founder at Fuji Immunopharmaceuticals Corp.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry Chen | M | - |
Curamir Therapeutics, Inc.
 Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA.
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | 10 years |
| Hong Jen Chang | M | 68 |
YFY Biotech Management Co
 YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | - |
| Li Chen Hsiao | M | - |
YFY Biotech Management Co
YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | - |
| Donald William Kufe | M | 79 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.
Harvard Medical School
| 7 years |
| Merit Cudkowicz | M | 61 |
Harvard Medical School
| - |
| Michael A. Weiss | M | - |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | 14 years |
| Bruce H. Frank | M | - |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | 14 years |
| David Scadden | M | 71 |
Harvard Medical School
| - |
| Vamsi Mootha | M | - |
Harvard Medical School
| 4 years |
| John Brooks | M | 73 |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | 15 years |
| Wu Nian | M | - |
LipoSeuticals, Inc.
 LipoSeuticals, Inc. Pharmaceuticals: MajorHealth Technology LipoSeuticals, Inc. operates as a specialty pharmaceuticals firm that focuses on the development of next-generation proprietary formulations of sterile injectable drugs, principally aimed at the domains of anesthesiology, oncology and infectious disease. It develops formulation of non-water-soluble drugs. The firm’s products include parenteral dosage forms and oral dosage forms. The company was founded by Wu Nian in 2012 and is headquartered in Monmouth Junction, NJ. | 12 years |
| Lin Zheng Chen | M | - |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | 10 years |
| Cigall Kadoch | M | 39 |
Harvard Medical School
| - |
| Christine Seidman | M | 71 |
Harvard Medical School
| 27 years |
| Keith Flaherty | M | 53 |
Harvard Medical School
| 15 years |
| Martha Crowninshield | F | - |
Harvard Medical School
| - |
| Jeffrey Flier | M | 76 |
Harvard Medical School
| 17 years |
| Mark Hochberg | M | - |
Harvard Medical School
| - |
| Patti A. Stoll | F | - |
Harvard Medical School
| - |
| William D. Carlson | M | - |
Harvard Medical School
| - |
| Jonathan G. Seidman | M | - |
Harvard Medical School
| 43 years |
| Arthur Ullian | M | - |
Harvard Medical School
| - |
| Nathanael Gray | M | - |
Harvard Medical School
| - |
| Barry S. Fogel | M | - |
Harvard Medical School
| 25 years |
| David W. Bates | M | - |
Harvard Medical School
| - |
| Timothy Gregg Ferris | M | 61 |
Harvard Medical School
| - |
| Sean P. Kelly | M | 53 |
Harvard Medical School
| - |
| Blaise Aguirre | M | 60 |
Harvard Medical School
| - |
| John W. Winkelman | M | - |
Harvard Medical School
| - |
| Gerald B. Pier | M | 72 |
Harvard Medical School
| - |
| David Weiner | M | - |
Harvard Medical School
| - |
| Michael Sherling | M | - |
Harvard Medical School
| - |
| William Gerald Austen | M | - |
Harvard Medical School
| - |
| Saurabh Saha | M | 47 |
Harvard Medical School
| - |
| Peter Libby | M | 77 |
Harvard Medical School
| 28 years |
| Seok-Hyun Yun | M | - |
Harvard Medical School
| - |
| Will Curry | M | - |
Harvard Medical School
| - |
| Marc Semigran | M | 67 |
Harvard Medical School
| 14 years |
| Robert Soiffer | M | 66 |
Harvard Medical School
| - |
| Ole Isacson | M | 64 |
Harvard Medical School
| 22 years |
| Maureen McNulty | F | - |
Harvard Medical School
| - |
| Anne Brownlee | F | - |
Harvard Medical School
| - |
| Jeremy N. Ruskin | M | - |
Harvard Medical School
| - |
| Susan Martin-Joy | F | - |
Harvard Medical School
| - |
| Nezam Afdhal | M | 67 |
Harvard Medical School
| 24 years |
| Charles A. Czeisler | M | - |
Harvard Medical School
| - |
| Atul Gawande | M | 58 |
Harvard Medical School
| - |
| Debra Metcalfe | F | - |
Harvard Medical School
| - |
| Claus Cursiefen | M | - |
Harvard Medical School
| - |
| Peter Sorger | M | - |
Harvard Medical School
| - |
| Leonard Schaeffer | M | 78 |
Harvard Medical School
| - |
| Reza Dana | M | - |
Harvard Medical School
| - |
| Rushika J. Fernandopulle | M | - |
Harvard Medical School
| - |
| Barbara McNeil | M | 83 |
Harvard Medical School
| 41 years |
| Choong-Chin Liew | M | - |
Harvard Medical School
| - |
| John Halamka | M | 61 |
Harvard Medical School
| 28 years |
| Dennis Selkoe | M | 80 |
Harvard Medical School
| 24 years |
| Bill Helman | M | 65 |
Harvard Medical School
| - |
| Laurence Paul | M | 59 |
Harvard Medical School
| - |
| Jerome Groopman | M | 72 |
Harvard Medical School
| 32 years |
| Marcus Smith | M | 58 |
Harvard Medical School
| - |
| William Gerald Austen | M | 94 |
Harvard Medical School
| 50 years |
| David Walt | M | 71 |
Harvard Medical School
| 7 years |
| Gary Gottlieb | M | 69 |
Harvard Medical School
| - |
| Rodman Moorhead | M | 80 |
Harvard Medical School
| - |
| Ronda Stryker | F | 69 |
Harvard Medical School
| - |
| Joshua Boger | M | 73 |
Harvard Medical School
| - |
| Freda Lewis-Hall | M | 69 |
Harvard Medical School
| - |
| Rakesh Kumar Jain | M | 74 |
Harvard Medical School
| 33 years |
| Mark A. Popovsky | M | - |
Harvard Medical School
| - |
| Phyllis Gardner | M | 73 |
Harvard Medical School
| 11 years |
| Raju S. Kucherlapati | M | 81 |
Harvard Medical School
| 23 years |
| Robert Steven Kaplan | M | 65 |
Harvard Medical School
| - |
| Dennis Ausiello | M | 78 |
Harvard Medical School
| - |
| George Demetri | M | 67 |
Harvard Medical School
| 36 years |
| Sally McNagny | M | - |
Harvard Medical School
| - |
| Anjana Rao | M | - |
Harvard Medical School
| - |
| Howard Cox | M | 80 |
Harvard Medical School
| - |
| Renu Gupta | M | 68 |
Harvard Medical School
| - |
| James Bradner | M | 52 |
Harvard Medical School
| - |
| Fabrice Balavoine | M | - |
Harvard Medical School
| - |
| Peter T. Lansbury | M | - |
Harvard Medical School
| - |
| Yvonne Greenstreet | M | 61 |
Harvard Medical School
| - |
| Marco A. Zenati | M | - |
Harvard Medical School
| - |
| Lee Josephson | M | - |
Harvard Medical School
| - |
| David P. White | M | - |
Harvard Medical School
| - |
| David Sinclair | M | 55 |
Harvard Medical School
| - |
| Richard Scranton | M | 57 |
Harvard Medical School
| - |
| Richard Rox Anderson | M | - |
Harvard Medical School
| - |
| Shaw H. Warren | M | - |
Harvard Medical School
| - |
| Ralph Weissleder | M | - |
Harvard Medical School
| - |
| Catherine McCormick Blair | F | - |
Harvard Medical School
| - |
| Richard Mulligan | M | 69 |
Harvard Medical School
| 28 years |
| David R. Elmaleh | M | 76 |
Harvard Medical School
| - |
| Peter L. Slavin | M | 66 |
Harvard Medical School
| - |
| James J. Mongan | M | 82 |
Harvard Medical School
| 28 years |
| Brenden Boot | M | - |
Harvard Medical School
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| George Farmer | M | - |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | - |
| Keith Gollust | M | 78 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 14 years |
| Eric W. Jacobson | M | 66 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 97.00% |
| Taiwan | 2 | 2.00% |
| Hong Kong | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lan Bo Chen
- Personal Network
